Actively Recruiting
Extensive Post-discharge Counselling and Phone-based Follow-up Intervention to Reduce Heart Failure Readmission at Komfo Anokye Teaching Hospital
Led by Komfo Anokye Teaching Hospital · Updated on 2025-08-03
150
Participants Needed
1
Research Sites
13 weeks
Total Duration
On this page
AI-Summary
What this Trial Is About
Heart failure is a leading cause of hospital admission in Ghana, accounting for about 88.3% of cardiac cases. Despite advances in treatment guidelines, many patients face repeated hospital readmissions, which increase the risk of death. This research aims to evaluate whether extensive counseling after discharge combined with regular phone follow-ups can reduce the rate of hospital readmissions within 30 and 90 days for heart failure patients at a major hospital in Ghana. The study compares two groups of heart failure patients: one receiving usual care, which includes counseling by their attending physicians and standard outpatient reviews, and another receiving additional extensive post-discharge counseling from a study doctor, pharmacist, or trained nurse, along with weekly phone follow-ups for the first 30 days and then every four weeks up to day 90. This approach aims to provide more support after hospital discharge to help reduce readmissions. Participants will be monitored over a 90-day period after discharge, with regular assessments through phone calls and outpatient visits. Researchers will track hospital readmission rates at both 30 and 90 days as the primary outcome. The study involves collecting information on patient adherence to treatment and follow-up care, aiming to better understand how enhanced support can impact heart failure management and reduce repeat hospitalizations.
CONDITIONS
Brief Title
30 Days and 90 Days Heart Failure Re-Admission at Komfo Anokye Teaching Hospital
Who Can Participate
Eligibility Criteria
You may qualify if you...
- Adults aged 18 years and above
- Diagnosed with heart failure
- NYHA class II to IV symptoms
- Able and willing to give informed consent
You will not qualify if you...
- NYHA class I symptoms
- Patients without access to a mobile phone
AI-Screening
AI-Powered Screening
Complete this quick 3-step screening to check your eligibility
Your Study Journey
Duration - 2 to 4 weeks
Participants are screened for eligibility to participate in the trial.
Duration - 90 days
Participants receive extensive post-discharge counselling and weekly telephone follow-ups for the first 30 days, then follow-ups every 4 weeks until day 90, in addition to their usual outpatient reviews.
Weekly telephone follow-ups for the first 30 days and follow-ups every 4 weeks until day 90
Trial Site Locations
Total: 1 location
1
Komfo Anokye Teaching Hospital
Kumasi, Ashanti Region, Ghana
Actively Recruiting
Research Team
S
SOLOMON GYABAAH
How is the study designed?
Study Type
INTERVENTIONAL
Masking
NONE
Allocation
RANDOMIZED
Model
PARALLEL
Primary Purpose
PREVENTION
Number of Arms
2
Similar Trials
Frequently Asked Questions
Have more questions? Get in touch with our team for quick support
Not the Right Trial for You?
Explore thousands of other clinical trials that might be a better match.
Sign up to get personalized trial recommendations delivered to your inbox.
Already have an account? Log in here